Comparative safety and efficacy of combination lipid lowering therapy versus high-intensity statin in elderly patients with atherosclerotic cardiovascular disease

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Jung-Joon Cha

Korea University Anam Hospital, Seoul (Korea (Republic of))

7 More presentations in this session

Presentation thumbnail

Association of GlycA, a composite 1H-NMR marker of systemic inflammation, with LDL particle size, frailty and epigenetic age acceleration

Associate Professor E. Fung (Hong Kong, CN)

Abstract Slides Video

Presentation thumbnail

Clinical outcomes of drug-coated balloon vs. drug-eluting stent in octogenarians with coronary artery disease: a propensity score-matched study

Professor A. Her (Chuncheon, KR)

Abstract Slides Video

Presentation thumbnail

Baseline levels of amino acid metabolites are associated with clinical outcomes in older persons

Doctor C. Wang (Beijing, CN)

Abstract Slides Video

Presentation thumbnail

Diagnostic value of 24-hour holter monitoring in nonagenarians: a single-center cohort study

Doctor A. Fonseca Vazao (Leiria, PT)

Abstract Slides Video

Presentation thumbnail

Combined effect of frailty and sarcopenia on the risk of cardiovascular disease: a longitude analysis in middle-aged and older adults

Miss M. Liu (Beijing, CN)

Abstract Slides Video

Access the full session

Session thumbnail

Cardiovascular disease in older adults (1)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Session

Changing face of lipid-lowering therapy

Congress Session

Refining efficacy and safety of lipid-lowering pharmacotherapy

Congress Session

Registries, observational, and other studies on lipids

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources